Comments on: CTL Sends FDA’s Sharfstein Letter Requesting Promised but Undelivered Expedited Review http://caretolive.com/2010-03-18/ctl-sends-sharfstein-letter-requesting-expedited-review/ CareToLive | Help Men With Late Stage Prostate Cancer | Provenge Now! Fri, 18 May 2012 07:37:29 +0000 http://wordpress.org/?v=2.3.1 By: john http://caretolive.com/2010-03-18/ctl-sends-sharfstein-letter-requesting-expedited-review/#comment-15530 john Thu, 25 Mar 2010 18:55:49 +0000 http://caretolive.com/2010-03-18/ctl-sends-sharfstein-letter-requesting-expedited-review/#comment-15530 Why would it take so long for FDA to approve since the data is not new, they looked at it once before. I'm afraid the FDA will reject Dendreon's Provenge for late stage prostate cancer or there would have been approval by now what are they waiting for? Why would it take so long for FDA to approve since the data is not new, they looked at it once before. I’m afraid the FDA will reject Dendreon’s Provenge for late stage prostate cancer or there would have been approval by now what are they waiting for?

]]>